Philips’ ADAC Laboratories and Elekta Oncology Systems have entered a global alliance to offer hospitals a clinical radiotherapy solution. The alliance will strive to integrate ePinnacle, a radiotherapy treatment planning system, with the Elekta
Philips’ ADAC Laboratories and Elekta Oncology Systems have entered a global alliance to offer hospitals a clinical radiotherapy solution. The alliance will strive to integrate ePinnacle, a radiotherapy treatment planning system, with the Elekta Precise Treatment System digital platform. The partnership encompasses joint marketing, sales, support, and development programs.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.